![Francesco Galimi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francesco Galimi
Director Técnico/Científico/I+D en ADICET BIO, INC. .
Fortuna: 123 179 $ al 30/06/2024
Cargos activos de Francesco Galimi
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ADICET BIO, INC. | Director Técnico/Científico/I+D | 01/09/2019 | - |
Adicet Therapeutics, Inc.
![]() Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Director Técnico/Científico/I+D | 01/09/2019 | - |
Historial de carrera de Francesco Galimi
Antiguos cargos conocidos de Francesco Galimi.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AMGEN INC. | Corporate Officer/Principal | 01/01/2015 | 01/01/2019 |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/01/2014 | 01/01/2015 |
ADICET BIO, INC. | Director Técnico/Científico/I+D | 15/09/2020 | - |
Formación de Francesco Galimi.
University of Turin | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Italia | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 6 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ADICET BIO, INC. | Health Technology |
AMGEN INC. | Health Technology |
Empresas privadas | 3 |
---|---|
resTORbio, Inc.
![]() resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
Adicet Therapeutics, Inc.
![]() Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Francesco Galimi
- Experiencia